Inari Medical Balance Sheet Health
Financial Health criteria checks 6/6
Inari Medical has a total shareholder equity of $434.8M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $697.2M and $262.5M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$111.54m |
| Equity | US$434.76m |
| Total liabilities | US$262.48m |
| Total assets | US$697.24m |
Recent financial health updates
Inari Medical (NASDAQ:NARI) Is In A Strong Position To Grow Its Business
Sep 18
We Think Inari Medical (NASDAQ:NARI) Can Afford To Drive Business Growth
Jun 18Recent updates
Inari Medical, Inc. (NASDAQ:NARI) Stocks Shoot Up 31% But Its P/S Still Looks Reasonable
Nov 07Investors Interested In Inari Medical, Inc.'s (NASDAQ:NARI) Revenues
Sep 23Inari Medical: A Touch Of Uncertainty And Overvaluation
Jul 05At US$43.23, Is It Time To Put Inari Medical, Inc. (NASDAQ:NARI) On Your Watch List?
Jun 18Market Participants Recognise Inari Medical, Inc.'s (NASDAQ:NARI) Revenues Pushing Shares 26% Higher
May 23Is Inari Medical, Inc. (NASDAQ:NARI) Trading At A 29% Discount?
May 02Inari Medical: Buy On Growing TAM
Mar 27Why We're Not Concerned Yet About Inari Medical, Inc.'s (NASDAQ:NARI) 25% Share Price Plunge
Mar 08Is Now The Time To Look At Buying Inari Medical, Inc. (NASDAQ:NARI)?
Dec 14A Look At The Fair Value Of Inari Medical, Inc. (NASDAQ:NARI)
Oct 23Inari Medical (NASDAQ:NARI) Is In A Strong Position To Grow Its Business
Sep 18Is Inari Medical, Inc. (NASDAQ:NARI) Potentially Undervalued?
Aug 14Inari Medical, Inc. (NASDAQ:NARI) Shares Could Be 23% Above Their Intrinsic Value Estimate
Jul 25We Think Inari Medical (NASDAQ:NARI) Can Afford To Drive Business Growth
Jun 18Inari Medical, Inc.'s (NASDAQ:NARI) Price In Tune With Revenues
Apr 17Financial Position Analysis
Short Term Liabilities: NARI's short term assets ($263.4M) exceed its short term liabilities ($148.8M).
Long Term Liabilities: NARI's short term assets ($263.4M) exceed its long term liabilities ($113.7M).
Debt to Equity History and Analysis
Debt Level: NARI is debt free.
Reducing Debt: NARI has no debt compared to 5 years ago when its debt to equity ratio was 107.4%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable NARI has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: NARI is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 32.5% per year.
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/21 13:54 |
| End of Day Share Price | 2025/01/21 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Inari Medical, Inc. is covered by 21 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Rescott | Baird |
| null null | Baird |
| Nisala Weerasuriya | Berenberg |